Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Enat 400 - Philippines FDA Drug Approval Details

Approvals/Philippines FDA/Enat 400

Approved

STANDARD

Enat 400

Mega Lifesciences Public Company Limited🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: c3851f74c65e1c0d
Company: Mega Lifesciences Public Company Limited
Type: Standard

Approval Details

Approval Id: c3851f74c65e1c0d
Drug Approval Philippines Name: Enat 400
Product Name: Enat 400
Registration Number: DR-XY26594
Brand Name: Enat 400
Generic Name: D-Alpha Tocopheryl Acetate
Dosage Form: Softgel Capsule
Dosage Strength: 400 IU
Manufacturer: Mega Lifesciences Public Company Limited
Importer: Metro Drug, Inc.
Distributor: Metro Drug, Inc.
Company Detail Path: /organization/mega-lifesciences-public-company-limited
Issuance Date: 26 April 2025
Expiry Date: 27 September 2031
Pharmacologic Category: Vitamin
Classification: Over-the-Counter (OTC)

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

c3851f74c65e1c0d

Type

Standard

Back to Philippines FDA Approvals